CYTOGEN CORPORATION
Cytogen is a biopharmaceutical company that is focused on the development and building of pharmaceutical products for cancer patients. Cytogen markets QUADRAMET, PROSTASCINT, CAPHOSOL, and SOLTAMOX. It also develops CYT-500, a third-generation radiolabeled antibody to treat prostate cancer. Cytogen was acquired by EUSA Pharma in May 2008. Cytogen was founded by Thomas J. McKearn in 1980. It is based in Princeton, New Jersey.
CYTOGEN CORPORATION
Industry:
Biotechnology Medical
Founded:
1980-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.cytogen.com
Total Employee:
101+
Status:
Active
Contact:
(609)750-8200
Technology used in webpage:
SPF Nginx DOSarrest Uniregistry
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Geistlich Pharma
Geistlich Pharma North America brings the leader in regenerative dentistry.
MabVax Therapeutics
MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Official Site Inspections
http://www.cytogen.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Cytogen Corporation"
Cytogen Corporation - Crunchbase Company Profile
Cytogen is a biopharmaceutical company that is focused on the development and building of pharmaceutical products for cancer patients. Cytogen markets QUADRAMET, PROSTASCINT, CAPHOSOL, and SOLTAMOX. It also …See details»
Organization | Cytogen
Organization Overview. First Clinical Trial. 2003 NCT00328614. First Marketed Drug. 1992 satumomab pendetide . First NDA Approval. 1992 satumomab ... CYTOGEN | Cytogen …See details»
Cytogen Company Profile 2024: Valuation, Investors, Acquisition
Cytogen General Information Description. Developer and marketer of therapeutic and diagnostic products as well as specialty pharmaceuticals. The company's therapeutic and diagnostic …See details»
Cytogen Corp - Company Profile and News - Bloomberg Markets
Company profile page for Cytogen Corp including stock price, company news, executives, board members, and contact informationSee details»
Cytogen - Crunchbase Investor Profile & Investments
Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment systems for cancer diagnosis and treatment in South Korea. It offers Smart Biopsy, an automated CTC …See details»
CytoGen, Inc. - LinkedIn
CytoGen, Inc. is a Circulating Tumor Cell (CTC) based Liquid Biopsy Platform company. We save lives and present relief enabling precision medicine, monitoring prognosis, early diagnosis …See details»
EUSA Pharma Completes Acquisition Of Cytogen Corporation
May 9, 2008 We plan to rapidly integrate the Cytogen organization, allowing us to compete with major players as we accelerate our search for additional specialty products to leverage our …See details»
Cytogen, Inc. (KOSDAQ: 217330) Company Profile & Overview
Dec 3, 2024 Cytogen, Inc., a biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea. The company offers cell isolators that enrich …See details»
Cytogen Corp : Company Profile for Cytogen Corporation
Jan 19, 2007 Founded in 1980, Cytogen is a biopharmaceutical company dedicated to advancing the care of cancer patients by building, developing, and commercializing a portfolio …See details»
CYTOGEN Corp. Information | CareersInPharmaceutical.com
Founded in 1980, Cytogen Corporation of Princeton, NJ, is a product-driven biopharmaceutical company. Cytogen's development pipeline consists of therapeutics targeting prostate-specific …See details»
Cytogen Company Profile - Office Locations, Competitors ... - Craft
Oct 28, 2024 Cytogen has 1 employees at their 1 location and ₩3.18 b in annual revenue in FY 2023. See insights on Cytogen including office locations, competitors, revenue, financials, …See details»
CytoGen, Inc. - LinkedIn
CytoGen, Inc. | 198 followers on LinkedIn. Enables preventive cancer care | CytoGen, Inc. is a Circulating Tumor Cell (CTC) based Liquid Biopsy Platform company. We save lives and …See details»
Cytogen - Crunchbase Company Profile & Funding
Cytogen provides cannabinoid products for traumatic injuries and surgeries for depression and anxiety. Their products include arctic roll-on gel, detoxamin, neuro formula tincture, sleep …See details»
Cytogen Inc. - BioCentury Company Profiles - BCIQ
Cytogen Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Cytogen Inc - ASCO Annual 2024
Jun 3, 2024 Cytogen, a diagnostics firm, facilitates access to live Circulating Tumor Cells (CTCs) isolated from blood. By examining live tumor cells, we enable subsequent downstream …See details»
Cytogen | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Cytogen Corporation - Contacts, Employees, Board Members
Organization. Cytogen Corporation . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Cytogen …See details»
CTC Story - CYTOGEN
CytoGen Inc. was established with the confidence of advanced technology in isolation of CTC from blood using High-Density Micro-porous (HDM) chips and gravity-based filtration method. …See details»
What is Cytogen? Company Culture, Mission, Values | Glassdoor
See what employees say it's like to work at Cytogen. Salaries, reviews, and more - all posted by employees working at Cytogen.See details»
CytoGen, Inc. (CytoGen, Inc.) - 药物管线_专利_临床试验_投融营收_ …
了解CytoGen, Inc. (CytoGen, Inc.)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验, 1篇新闻和9篇文献，疾病领域:肿瘤，内分泌与代谢疾病，技术平台:抗体偶联核素，诊断用放 …See details»